Treatment Options for Kawasaki Disease
Kawasaki disease is an illness that causes inflammation in the walls of blood vessels throughout the body, mostly affecting children under the age of five. It often leads to a high fever, rash, swollen hands and feet, red eyes, and cracked lips. If untreated, it can lead to severe complications.
Treatment for Kawasaki Disease aims to:
- Reduce inflammation: Inflammation is a major factor in Kawasaki Disease, and reducing it is crucial for treatment. The use of immunoglobulin (IVIG) in combination with aspirin is recommended as a first-line treatment. IVIG is an antibody that can decrease inflammation in blood vessels.
- Prevent coronary artery damage: One of the main concerns in Kawasaki Disease is the potential for coronary artery abnormalities and acquired heart disease in children. Treatment aims to prevent these complications by suppressing acute inflammation within 10 days of the onset of illness.
- Lower fever: Treatment also focuses on lowering fever, which is a common symptom of Kawasaki Disease. High doses of aspirin can help bring down fever and reduce inflammation. However, it's important to note that aspirin should only be used under the specific prescription and guidance of a doctor.
- Reduce the risk of complications: Kawasaki Disease can lead to cardiovascular complications, so treatment aims to reduce this risk. IVIG can help decrease blood vessel inflammation and lower the risk of cardiovascular problems. Corticosteroids may also be used to reduce the risk of heart complications and relieve symptoms like rashes and fever.
It's important to note that while treatment can help manage symptoms and prevent complications, it may not be curative or slow the progression of Kawasaki Disease. The focus is on controlling symptoms, reducing inflammation, and preventing further damage to the coronary arteries.
The recommended potential treatments for Kawasaki Disease can be grouped into different categories, including initial treatment, medications, and therapeutic procedures. Here are the details:
Initial Treatment:
- Intravenous Immunoglobulin (IVIG): IVIG is the gold standard initial treatment for Kawasaki Disease. It involves the administration of immunoglobulins through a vein. The intended impact of IVIG is to reduce inflammation and prevent the development of coronary artery lesions (CALs), which are a common complication of Kawasaki Disease.
Medications:
- Acetylsalicylic Acid (ASA): ASA, also known as aspirin, is another important medication used in the treatment of Kawasaki Disease. It is typically given in high doses during the acute phase of the illness and then in lower doses for a longer period. ASA helps reduce fever and inflammation and prevent blood clot formation.
- Corticosteroids: In some cases, corticosteroids may be considered as an additional treatment option for Kawasaki Disease. However, their use is still controversial, and they are not part of the standard first-line treatment. Corticosteroids have anti-inflammatory effects and may be used if a patient does not respond adequately to IVIG or has certain complications.
- Monoclonal Antibodies: Monoclonal antibodies such as anakinra and infliximab may be considered as rescue therapies for refractory cases of Kawasaki Disease. These medications target specific components of the immune system to reduce inflammation.
Therapeutic Procedures:
- Additional IVIG: If a patient does not respond adequately to the initial IVIG treatment, an additional dose of IVIG may be recommended as a therapeutic procedure.
- Other Medications: In severe refractory cases, other medications such as ulinastatin, cyclosporine, methotrexate, or plasma exchange may be considered. However, these options are typically reserved for specific situations due to potential adverse reactions.
It's important to note that while these treatments are commonly used for Kawasaki Disease, each patient's situation may vary. The specific treatment plan should always be discussed with a healthcare professional who can consider individual factors and make appropriate recommendations.